• Stantec published two peer-reviewed papers in April in Critical Reviews in Toxicology on drug stability risks during multi-year Mars missions.
• Research with NASA’s Johnson Space Center developed a five-step risk-assessment framework for medication degradation under radiation, high CO2, expired shelf life.
• Framework uses terrestrial evidence and computational modeling to rank medication risks when direct spaceflight data is limited.
• Case studies flagged some exploration-mission drugs for deeper review, while others appeared low-risk under expected exposure scenarios.
• Results aim to guide pharmaceutical selection, packaging, storage, substitution plans, and future testing protocols for deep-space missions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stantec Inc. published the original content used to generate this news brief on May 27, 2026, and is solely responsible for the information contained therein.